Summary
Some environmental and physiological factors that affect the toxicokinetic behaviors of organic solvents were examined using a physiologically based pharmacokinetic model developed for trichloroethylene (TRI). The conclusions are as follows: 1 ) Body fat content substantially affects the kinetic behavior of TRI: the TRI concentration in blood and the urinary excretion rate of its metabolites are higher in slim men than in obese men during exposure, but these parameters eventually become higher in obese men. 2) There is a sex difference in the pharmacokinetic profiles of TRI. Although retention of TRI in the body is greater in men than in women, the blood concentration of TRI in women is higher than in men 16 hours after exposure. 3) Because of increased pulmonary ventilation and cardiac output, physical activity (workload) during exposure greatly increases the blood concentration of TRI and the urinary excretion of its metabolites, whereas the activity after exposure has only a marginal influence. 4) Ethanol-induced inhibition of TRI metabolism causes a marked change in the kinetic behavior when the TRI exposure level is low, whereas enzyme induction by ethanol significantly affects the kinetics only when the exposure concentration is high. The effect of enzyme induction differs from compound to compound. Whether the compound concerned is a perfusion-limited substrate (TRI, for example) or a capacity-limited substrate (1,1,1-trichloroethane, for example) determines the extent of the effect. 5) Metabolic interaction between solvent vapors inhaled simultaneously may not become apparent until the exposure level increases to a degree that will overload the enzyme capacity.
Similar content being viewed by others
References
Davis NR, Mapleson WW (1981) Structure and quantification of a physiological model of the distribution of injected agents and inhaled anaesthetics. Br J Anaesth 53:399–405
Engstrom K, Riihimaki V, Laine A (1984) Urinary disposition of ethylbenzene and m-xylene in man following separate and combined exposure. Int Arch Occup Environ Health 54:355–363
Endoh K, Kaneko T, Sato A (1989) A physiologically based pharmacokinetic model to describe the transfer of organic solvents in human body. Jpn J Ind Health 31: 335–341 (in Japanese with an English Abstract)
Fernandez JG, Droz PO, Humbert BE, Caperos JR (1977) Trichloroethylene exposure. Simulation of uptake, excretion and metabolism using a mathematical model. Br J Ind Med 34:43–55
Fiserova-Bergerova V, Vlach J, Singhal K (1974) Simulation and prediction of uptake, distribution, and excretion of organic solvents. Br J Ind Med 31:45–52
Guyton AC (1977) Basic human physiology: normal function and mechanisms of disease. 12th ed. Saunders, Philadelphia London Toronto, p 247
Koizumi A (1989) Potential of physiologically based pharmacokinetics to amalgamate kinetic data of trichloroethylene and tetrachloroethylene obtained in rat and man. Br J Ind Med 46:239–249
Liira J, Riihimaki V, Engstrom K, Pfaffli P (1988) Coexposure of man to m-xylene and methyl ethyl ketone. Scand J Work Environ Health 14:322–327
Liira J, Riihimaki V, Engstrom K (1990) Effects of ethanol on the kinetics of methyl ethyt ketone in man. Br J Ind Med 47:324–330
Muller G, Spassowski M, Henschler D (1975) Metabolism of trichloroethylene in man. 111. Interaction of trichloroethylene and ethanol. Arch Toxicol 33:173–189
Nakajima T, Okino T, Okuyama S, Kaneko T, Yonekura I, Sato A (1988) Ethanol-induced enhancement of trichloroethylene metabolism and hepatotoxicity: difference from the effect of phenobarbital. Toxicol Appl Pharmacol 94:227–237
Riihimaki V, Savolainen K, Pfaffli P, Pekari K, Sippel HW, Laine A (1982) Metabolic interaction between m-xylene and ethanol. Arch Toxicol 49: 253–263
Sato A, Nakajima T (1979) Dose-dependent metabolic interaction between benzene and toluene in vivo and in vitro. Toxicol Appl Pharmacol 48:249–256
Sato A, Nakajima T (1985) Enhanced metabolism of volatile hydrocarbons in rat liver following food deprivation, restricted carbohydrate intake and administration of ethanol, phenobarbital, polychlorinated biphenyl and 3-methylcholanthrene: a comparative study. Xenobiotica 15:67–75
Sato A, Nakajima T (1987) Pharmacokinetics of organic solvent vapors in relation to their toxicity. Scand J Work Environ Health 13:81–93
Sato A (1991) The effect of environmental factors on the pharmacokinetic behaviour of organic solvent vapours. Ann Occup Hyg 35:525–541
Sato A, Endob K, Kaneko T, Johanson G (1991a) A simulation study of physiological factors affecting pharmacokinetic behaviour of organic solvent vapours. Br J Ind Med 48:342–347
Sato A, Endoh K, Kaneko T, Johanson G (1991b) Effects of consumption of ethanol on the biological monitoring of exposure to organic solvent vapours: a simulation study with trichloroethylene. Br J Ind Med 48:548–556
Wallen M, Naslund PH, Nordqvist MB (1984) The effect of ethanol on the kinetics of toluene in man. Toxicol Appl Pharmacol 76:414–419
Wallen M, Holms S, Nordqvist MB (1985) Coexposure to toluene and p-xylene in man: uptake and elimination. Br J Ind Med 42:111–116
Wigaeus E, Lof A, Nordqvist MB (1984) Uptake, distribution, metabolism and elimination of styrene in man. A comparison between single exposure and co-exposure with acetone. Br J Ind Med 41:539–546
Wilson HK, Robertson SM, Waldron HA, Gompertz D (1983) Effect of alcohol on the kinetics of mandelic acid excretion in volunteers exposed to styrene vapour. Br J Ind Med 40:75–80
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sato, A. Confounding factors in biological monitoring of exposure to organic solvents. Int. Arch Occup Environ Heath 65 (Suppl 1), S61–S67 (1993). https://doi.org/10.1007/BF00381309
Issue Date:
DOI: https://doi.org/10.1007/BF00381309